-
Expansions in public health insurance programs are designed to offer a safety net to vulnerable Americans unable to obtain basic health insurance and regular access to medical care.
-
Patients who participate in clinical trials not only have access to newer, experimental treatments, they also have access to more routine medical checkups and state-of-the-art technologies. Yet for many women, participation in medical research studies is still not an option.
-
-
At many professional meetings and workshops, clinical trial investigators and coordinators crowd into presentations offering advice on recruiting and retaining women and minority subjects.
-
While interest in complementary and alternative medicine (CAM) research increases in the United States, there remain some significant challenges to properly designing these studies, an expert states.
-
AMA wants all clinical trial results in database
-
Would you like to be able to boast that your organization performed hundreds of surgeries without a single infection or reduced rates of surgical infections dramatically? By making specific process changes, these impressive results can be achieved.
-
Brinker F. Coming clean on supplements designated the 'Dirty Dozen'. Altern Med Alert 2004;7(8):85-95.
-
Greenfield RH. Antibiotics for cardiovascular disease prevention. Altern Med Alert 2004;7(8):95-96.
-
The authors review the classic course of common pediatric diseases associated with rashes, including varicella-zoster virus, herpes simplex virus (HSV), roseola, and rubella. Understanding the classic patterns, disease progression, high-risk populations, and potential complications allow the ED physician to avoid unnecessary testing in low-risk patients with a classic presentation, and aggressively approach potentially significant rashes in high-risk populations (e.g., neonatal HSV). This article also is designed to increase ED physicians awareness of treatment strategies associated with common viral exanthems.